ADAPT Legal
Sherman Ikemoto
Group Director
Cadence
Sherman Ikemoto is the Sales Development Group Director at Cadence Design Systems, where he leads global business development for the innovative Reality DC Digital Twin solution. With a passion for addressing challenges in data center design, performance, and sustainability, Sherman brings extensive expertise to the forefront of this critical industry. Previously, Sherman served as Managing Director and Board Member at Future Facilities, the pioneer of the original data center Digital Twin, and as North America Sales and Marketing Director at Flomerics, where he helped introduce computational fluid dynamics modeling to electronics cooling design. During his tenure at Future Facilities, Sherman was a sought-after speaker at prominent industry events like ITW, Data Center World, Uptime Symposium, and Data Center Dynamics. Sherman holds a Bachelor of Science in Mechanical Engineering (BSME) from San Jose State University, where he was a member of the Tau Beta Pi engineering honor society, and a Master of Science in Mechanical Engineering (MSME) from Santa Clara University. His career reflects a deep commitment to advancing sustainable and efficient technologies for the data center industry.
Giri Pathmanaban
Partner
Cleary Gottlieb
Giri Pathmanaban’s practice focuses on high-stakes patent, trade secret, and intellectual property contractual disputes. He has successfully represented clients in federal district courts, the International Trade Commission (ITC), and Patent Office proceedings. Giri simplifies complex issues, communicates effectively with clients and juries, and advises clients on IP issues to help achieve their business objectives. Giri’s technical background in computer science and engineering enables him to develop and execute winning legal strategies across a range of industries, inside and outside the courtroom. He has litigated cases in a range of industries, including cybersecurity, AI and machine learning, semiconductors, computer networking and electronic devices, internet and cloud computing, and medical devices and healthcare.
Erim Sezer
Director, Data Enablement & Digitization
Bayer
Maxine Carrington
Chief People Officer
Northwell Health
- How employers are integrating fertility, menopause, and maternal health into employee health plans.
- Addressing workplace challenges like menstrual health, caregiving, and chronic conditions.
- The ROI of Women's Health Investment – How employer-driven health initiatives improve retention.
Brain Health
Nutrition and Food as Medicine
Healthcare Costs and Outcomes
Maxine Carrington
Chief People Officer
Northwell Health
Jennesa Atherton
Head of Clinical Affairs
Sword Health
- Exploring how housing, nutrition, identity, and income shape maternal outcomes.
- Highlighting programs and solutions that integrate social support with clinical care.
- Discussing actionable strategies in the clinical setting that embed accessibility and education into maternal health systems.
Nutrition and Food as Medicine
Maternal Health
Nawal Nour
Chair & Director of Obstetrics & Gynecology
Mass General Brigham
Eva Luo
OBGYN & Head of Obstetrics, Design & Delivery
Pomelo Care
Pooja Mehta
Vice President, Population Health
Cityblock Health
Lucy Perez
Senior Partner, McKinsey & Co
Global Leader, McKinsey Health Institute
Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.
Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America. She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.
Lucy works extensively with number of biopharma and life science clients on broad range of topics, with recent focus on ESG/ sustainability, evidence generation, and digital/analytics programs to improve patient outcomes and support sustainable, inclusive growth.
Led efforts for a leading biopharma to define their ESG strategy, partnership strategy, and stakeholder engagement approach
Led efforts for a leading biopharma to embed health equity as a core principle in their R&D priorities and ways of working across the value chain
Led efforts to assess internal and external portfolio productivity and pricing models to optimize the R&D strategy and redesign the organization for a top pharmaceutical company
Led efforts for a leading biopharma to transform how it engages with customers through digital transformation, applying advanced analytics and embedding agile ways of working across their six largest markets that delivered $300M+ of near-term growth
Sponsor of McKinsey’s Early Stage Investor Conference, an annual event convening 200+ entrepreneurs and 1000+ investors interested in bio/med/health tech and sustainability innovation
Before joining McKinsey, Lucy was a research fellow at Memorial Sloan-Kettering Cancer Center, where she was involved in the development of novel treatments for solid tumors. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies. She is co-inventor on multiple patents and has published in peer-reviewed journals.
Nawal Nour
Chair & Director of Obstetrics & Gynecology
Mass General Brigham